Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-597-5 | CAS number: 97-63-2
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 370.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- By inhalation
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Modified dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 267 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 10.8 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Modified dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The long-term DNELs for EMA for all relevant routes and groups were derived by interpolation between the respective DNELs for MMA and n-BMA, weighed by the difference in molecular weight.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 76 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Modified dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 189.8 mg/m³
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- low hazard (no threshold derived)
- Most sensitive endpoint:
- irritation (respiratory tract)
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 6.5 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- DNEL derivation method:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
- Modified dose descriptor starting point:
- other: Interpolation between the respective DNELs of the closest analogous substances in the category, i.e. MMA and nBMA.
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The long-term DNELs for EMA for all relevant routes and groups were derived by interpolation between the respective DNELs for MMA and n-BMA, weighed by the difference in molecular weight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
